116 related articles for article (PubMed ID: 18066827)
1. Design, synthesis, and anti-tumor activity of 4'-thionucleosides as potent and selective agonists at the human A3 adenosine receptor.
Jeong LS; Lee HW; Kim HO; Jung JY; Gunaga P; Lee SK; Lee EJ; Chun MW; Gao ZG; Jacobson KA; Moon HR
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1565-8. PubMed ID: 18066827
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor.
Jeong LS; Lee HW; Kim HO; Jung JY; Gao ZG; Duong HT; Rao S; Jacobson KA; Shin DH; Lee JA; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
Bioorg Med Chem; 2006 Jul; 14(14):4718-30. PubMed ID: 16603368
[TBL] [Abstract][Full Text] [Related]
3. N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.
Jeong LS; Jin DZ; Kim HO; Shin DH; Moon HR; Gunaga P; Chun MW; Kim YC; Melman N; Gao ZG; Jacobson KA
J Med Chem; 2003 Aug; 46(18):3775-7. PubMed ID: 12930138
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.
Jeong LS; Pal S; Choe SA; Choi WJ; Jacobson KA; Gao ZG; Klutz AM; Hou X; Kim HO; Lee HW; Lee SK; Tosh DK; Moon HR
J Med Chem; 2008 Oct; 51(20):6609-13. PubMed ID: 18811138
[TBL] [Abstract][Full Text] [Related]
5. Development of potent and selective human A3 adenosine receptor agonists.
Jeong LS; Lee HW; Jacobson KA; Lee SK; Chun MW
Nucleic Acids Symp Ser (Oxf); 2005; (49):31-2. PubMed ID: 17150618
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.
Choi WJ; Lee HW; Kim HO; Chinn M; Gao ZG; Patel A; Jacobson KA; Moon HR; Jung YH; Jeong LS
Bioorg Med Chem; 2009 Dec; 17(23):8003-11. PubMed ID: 19879151
[TBL] [Abstract][Full Text] [Related]
7. Alternative and improved syntheses of highly potent and selective A3 adenosine receptor agonists, Cl-IB-MECA and thio-Cl-IB-MECA.
Hou X; Lee HW; Tosh DK; Zhao LX; Jeong LS
Arch Pharm Res; 2007 Oct; 30(10):1205-9. PubMed ID: 18038898
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
[TBL] [Abstract][Full Text] [Related]
9. D-4'-thioadenosine derivatives as highly potent and selective agonists at the human A3 adenosine receptor.
Lee HW; Shin DH; Jeong JY; Kim HO; Chun MW; Melman N; Gao ZG; Jacobson KA; Jeong LS
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):607-9. PubMed ID: 16247997
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptors.
Lee HW; Kim HO; Choi WJ; Choi S; Lee JH; Park SG; Yoo L; Jacobson KA; Jeong LS
Bioorg Med Chem; 2010 Oct; 18(19):7015-21. PubMed ID: 20826090
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of truncated 4'-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists.
Hou X; Pal S; Choi WJ; Kim HO; Tipnis A; Jacobson KA; Jeong LS
Nucleic Acids Symp Ser (Oxf); 2008; (52):641-2. PubMed ID: 18776543
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.
Jeong LS; Choe SA; Gunaga P; Kim HO; Lee HW; Lee SK; Tosh DK; Patel A; Palaniappan KK; Gao ZG; Jacobson KA; Moon HR
J Med Chem; 2007 Jul; 50(14):3159-62. PubMed ID: 17555308
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2-alkynyl substituted 4'-thioadenosine derivatives and their binding affinities at the adenosine receptors.
Liang CW; Choi WJ; Jeong LS
Arch Pharm Res; 2008 Aug; 31(8):973-7. PubMed ID: 18787783
[TBL] [Abstract][Full Text] [Related]
14. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of 5'-deoxy-4'-thio-L-nucleosides.
Cong L; Zhou W; Jin D; Wang J; Chen X
Chem Biol Drug Des; 2010 Jun; 75(6):619-27. PubMed ID: 20337785
[TBL] [Abstract][Full Text] [Related]
16. Development of A3 adenosine receptor ligands.
Jeong LS
Nucleic Acids Symp Ser (Oxf); 2008; (52):79-80. PubMed ID: 18776262
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor.
Jeong LS; Lee HW; Jacobson KA; Kim HO; Shin DH; Lee JA; Gao ZG; Lu C; Duong HT; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
J Med Chem; 2006 Jan; 49(1):273-81. PubMed ID: 16392812
[TBL] [Abstract][Full Text] [Related]
18. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
19. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
Kim GD; Oh J; Jeong LS; Lee SK
Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
[TBL] [Abstract][Full Text] [Related]
20. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
